2014
DOI: 10.1097/nt.0000000000000044
|View full text |Cite
|
Sign up to set email alerts
|

Nutrition Strategies for Patients on New Incretin Therapies for Type 2 Diabetes

Abstract: or 9.3% of the population (www.diabetes.org/diabetes-basis/ statistics). Medications for the treatment of type 2 diabetes targeting incretin hormones for improved glycemic control have emerged as favorable second-line additions to metformin and lifestyle changes. In this article, we discuss the benefits of using glucagon-like peptide 1 receptor agonist medications and dipeptidyl peptidase 4 inhibitors along with their implications for weight and dietary management of type 2 diabetes. Nutr Today. 2014;49(5):254… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 29 publications
(15 reference statements)
0
0
0
Order By: Relevance